Enanta Pharmaceuticals
(NASDAQ) ENTA
Enanta Pharmaceuticals Financials at a Glance
Market Cap
$398.96M
Revenue (TTM)
$69.21M
Net Income (TTM)
-$61.98M
EPS (TTM)
-$2.59
P/E Ratio
-5.29
Dividend
$0.00
Beta (Volatility)
1.00 (Low)
Dividend
$0.00
Beta (Volatility)
1.00 (Low)
Price
$14.02
Volume
6,143.224
Open
$13.72
Price
$14.02
Volume
6,143.224
Open
$13.72
Previous Close
$13.72
Daily Range
$13.72 - $13.82
52-Week Range
$6.44 - $17.15
Estimated Earnings Date
Aug 10, 2026
Dividend
$0.00
Beta (Volatility)
1.00 (Low)
Price
$14.02
Volume
6,143.224
Open
$13.72
Previous Close
$13.72
Daily Range
$13.72 - $13.82
52-Week Range
$6.44 - $17.15
Estimated Earnings Date
Aug 10, 2026
ENTA News
ENTA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Enanta Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
120
CEO
Jay R. Luly, PhD
Website
www.enanta.comHeadquarters
Watertown, MA 02472, US
ENTA Financials
Key Financial Metrics (TTM)
Gross Margin
98.25%
Operating Margin
-87.24%
Net Income Margin
-89.56%
Return on Equity
-64.04%
Return on Capital
-32.11%
Return on Assets
-19.70%
Earnings Yield
-18.90%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$398.96M
Shares Outstanding
29.08M
Volume
6.14K
Avg. Volume
178.91K
Financials (TTM)
Gross Profit
$68.00M
Operating Income
-$60.38M
EBITDA
-$46.56M
Operating Cash Flow
-$7.84M
Capital Expenditure
-$1.77M
Free Cash Flow
-$9.61M
Cash & ST Invst.
$163.77M
Total Debt
$186.62M
Enanta Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$17.16M
+15.0%
Gross Profit
$15.95M
+6.9%
Gross Margin
92.95%
N/A
Market Cap
$398.96M
N/A
Market Cap/Employee
$3.05M
N/A
Employees
131
N/A
Net Income
-$13.09M
+42.2%
EBITDA
-$8.56M
+59.3%
Quarterly Fundamentals
Total Cash
$163.77M
-15.3%
Total Debt
$186.62M
-13.7%
Accounts Receivable
$7.83M
-80.7%
Inventory
$0.00
N/A
Long Term Debt
$151.40M
-17.4%
Short Term Debt
$35.22M
+7.1%
Return on Assets
-19.70%
N/A
Return on Invested Capital
-22.51%
N/A
Free Cash Flow
-$7.17M
+55.3%
Operating Cash Flow
-$7.16M
+46.9%